As high prices continue for freight and raw materials, companies in the health care supply chain are coming up with strategies to weather those costs. Customers may ultimately foot the bill.
Even as the delta variant increases COVID-19 case numbers in the U.S., distributors and manufacturers are reporting they had too much PPE in the second quarter.
After years of negotiations, several major drug distributors have proposed a settlement to resolve claims they contributed to the opioid crisis.
Medical gloves and gowns in the U.S. have been in short supply during the pandemic. Now HHS is researching ways to expand domestic production.
Companies in the health care supply chain are preparing to change gears as COVID-19 cases fall and health care utilization returns to normal levels.
Health care distributors ramped up distribution of PPE and vaccines during the pandemic but normal health care usage fell.
In today’s edition of The Daily Dash, project44 has secured $100 million in funding; plus, Amazon was forced to close a warehouse days before Christmas because of rising COVID cases and McKesson has started shipping Moderna’s vaccine.
The flow of vaccines to the American public is slowly picking up pace in week two. A lot of coordination among manufacturers, logistics companies, carriers and the government is required.
Team McKesson is implementing Phase 2 of Operation Warp Speed on Sunday, delivering the first Moderna COVID vaccines across the nation.
The Defense Department, the biggest logistics organization in the world, is putting its expertise to work developing a strategic plan for efficiently delivering a COVID vaccine to every corner of the country.
